Creating new antiviral drugs: Katherine Seley-Radtke’s innovative “fleximer” research to receive $3.5M from NIH

Thumbnail Image

Files

Creating New Antiviral Drugs_ Katherine Seley-Radtke’s Innovative “fleximer” Research To Receive $3.5M From NIH - UMBC_ University Of Maryland, Baltimore County.pdf (1.91 MB)

Links to Files

https://umbc.edu/stories/antiviral-research-receives-3-5m-from-nih/

Permanent Link

http://hdl.handle.net/11603/31921

Collections

About UMBC and Its People
UMBC Chemistry & Biochemistry Department
UMBC Staff Collection

Author/Creator

Author/Creator ORCID

Date

2022-06-10

Type of Work

articles
Text

Department

Program

Citation of Original Publication

Hansen, Sarah. “Creating New Antiviral Drugs: Katherine Seley-Radtke’s Innovative ‘Fleximer’ Research To Receive $3.5M From NIH,” UMBC News. Science & Tech. June 10, 2022. https://umbc.edu/stories/antiviral-research-receives-3-5m-from-nih/.

Rights

This item is likely protected under Title 17 of the U.S. Copyright Law. Unless on a Creative Commons license, for uses protected by Copyright Law, contact the copyright holder or the author.

Subjects

Katherine Seley-Radtke
UMBC Chemistry & Biochemistry Department

Abstract